Difference between revisions of "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2) (Q10321)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: has part (P22): References (from DOI: 10.1007/s11886-020-01293-2) (Q10994), #quickstatements; #temporary_batch_1592927589940)
 
(15 intermediate revisions by the same user not shown)
Property / Full Citation Data stringProperty / Full Citation Data string
-
Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34. doi:10.1007/s11886-020-01293-2
+
Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
Property / Cites Publication
 +
Property / Cites Publication: Hu H, et al, Eur Heart J (2020), cited as Ref 29 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Kwong JC, et al, N Engl J Med (2018), cited as Ref 30 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Harris JE, et al, Int J Cardiol Heart Vasc (2019), cited as Ref 31 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Ludwig A, et al, BMC Cardiovasc Disord (2015), cited as Ref 32 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Grasselli G, et al, JAMA (2020), cited as Ref 33 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Walkey AJ, et al, Chest (2014), cited as Ref 34 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / Cites Publication
 +
Property / Cites Publication: Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2 / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Conflict of Interest (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank
Property / has part
 +
Property / has part: References (from DOI: 10.1007/s11886-020-01293-2) / rank
 +
Normal rank

Latest revision as of 15:53, 23 June 2020

Research article published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34
Language Label Description Also known as
English
Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)
Research article published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34

    Statements

    Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
    Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (English)